Patients receiving subcutaneous daratumumab have less chair time and premedication than those receiving IV formulation, says ...

BD Announces First Pharma-Sponsored Clinical Trial Using BD Libertas™ Wearable Injector Technology for Biologic Drugs FRANKLIN LAKES, N.J., July 23, 2025 / Biotech Newswire / -- BD (Becton, Dickinson ...

In July 2025, CSL Behring conducted a study in China is to investigate the pharmacokinetics (PK) of rVIII-SingleChain after ...

Panelists discuss how challenges such as extended nursing workflow, patient hesitancy, limited formulation indications, ...

Panelists discuss how subcutaneous (SubQ) and intravenous (IV) oncology therapies will continue to coexist, with ...

Discover how Obexelimab's unique B-cell inhibition and pivotal Phase 3 IgG4 results could drive Zenas BioPharma, Inc.'s ...

BD (Becton, Dickinson and Company) announces the first pharma-sponsored combination product clinical trial using the BD Libertas™ Wearable Injector for subcutaneous delivery of complex biologics.

Lonapegsomatropin is a pegylated prodrug of the human growth hormone, somatropin, administered as a subcutaneous injection once-weekly.

The opinion is based on positive data from the phase 3 Balance study, which showed a significant reduction of triglycerides ...

The prefilled, patient-ready-to-use system is said to support delivery of high-viscosity biologics of up to 50 centipoise.

KalVista Pharmaceuticals faces a shrinking HAE market, tough competition, and launch uncertainty despite FDA approval. Read ...

Patna: In order to improve family planning in the state, the govt decided to provide MPA-Subcutaneous, a form of injection, which is effective in cont.